作为ResNet发明者之一,何恺明自2024年离职me ta进入学术界后,也令更多优秀的年轻人受益——年轻学者有机会更加深入且没有ROI制约地推进AI基础研究和前沿突破。
Following completion of the ongoing Phase 2a proof-of-pharmacology study with BMB-101, Bright Minds plans to select and advance a 5-HT 2C molecule (BMB-105) as the dedicated compound for the PWS ...